Bhatti; Balwinder S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bhatti; Balwinder S..The latest application filed is for "n-aryl diazaspirocyclic compounds and methods of preparation and use thereof".

Company Profile

0.9.15

Bhatti; Balwinder S. - Winston-Salem NC
Bhatti; Balwinder S. - Lexington KY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
N-aryl Diazaspirocyclic Compounds And Methods Of Preparation And Use Thereof App 20110105548 - Bhatti; Balwinder S. ; et al.	2011-05-05
N-aryl diazaspirocyclic compounds and methods of preparation and use thereof Grant 7,923,559 - Bhatti , et al. April 12, 2	2011-04-12
Pharmaceutical Compositions And Methods For Relieving Pain And Treating Central Nervous System Disorders App 20100179183 - Bhatti; Balwinder S. ; et al.	2010-07-15
Pharmaceutical Compositions And Methods For Relieving Pain And Treating Central Nervous System Disorders App 20100152228 - Breining; Scott R. ; et al.	2010-06-17
Compounds Capable Of Activating Cholinergic Receptors App 20100121061 - Caldwell; William S. ; et al.	2010-05-13
Pharmaceutical Compositions and Methods for Relieving Pain and Treating Central Nervous System Disorders App 20080242693 - Breining; Scott R. ; et al.	2008-10-02
N-Aryl Diazaspirocyclic Compounds and Methods of Preparation and Use Thereof App 20080214591 - Bhatti; Balwinder S. ; et al.	2008-09-04
Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders Grant 7,402,592 - Breining , et al. July 22, 2	2008-07-22
N-aryl diazaspiracyclic compounds and methods of preparation and use thereof Grant 7,375,110 - Bhatti , et al. May 20, 2	2008-05-20
N-aryl diazaspiracyclic compounds and methods of preparation and use thereof Grant 7,291,731 - Bhatti , et al. November 6, 2	2007-11-06
Pharmaceutical Compositions and Methods for Effecting Dopamine Release App 20070185086 - Bencherif; Merouane ; et al.	2007-08-09
Pharmaceutical compositions and methods for effecting dopamine release Grant 7,214,686 - Bencherif , et al. May 8, 2	2007-05-08
Compounds Capable of Activating Cholinergic Receptors App 20060293289 - Caldwell; William S. ; et al.	2006-12-28
Compounds capable of activating cholinergic receptors Grant 7,045,538 - Caldwell , et al. May 16, 2	2006-05-16
Use of N-aryl diazaspiracyclic compounds in the treatment of addiction App 20060058328 - Bhatti; Balwinder S. ; et al.	2006-03-16
Compounds capable of activating cholinergic receptors Grant 6,979,695 - Caldwell , et al. December 27, 2	2005-12-27
Pharmaceutical Compositions And Methods For Relieving Pain And Treating Central Nervous System Disorders App 20050282823 - Breining, Scott R. ; et al.	2005-12-22
N-aryl diazaspiracyclic compounds and methods of preparation and use thereof App 20050272739 - Bhatti, Balwinder S. ; et al.	2005-12-08
N-aryl diazaspiracyclic compounds and methods of preparation and use thereof Grant 6,956,042 - Bhatti , et al. October 18, 2	2005-10-18
Compounds capable of activating cholinergic receptors App 20050148611 - Caldwell, William S. ; et al.	2005-07-07
Pharmaceutical compositions and methods for effecting dopamine release App 20040220214 - Bencherif, Merouane ; et al.	2004-11-04
N-aryl diazaspiracyclic compounds and methods of preparation and use thereof App 20040067930 - Bhatti, Balwinder S. ; et al.	2004-04-08
Compounds capable of activating cholinergic receptors App 20030125345 - Caldwell, William S. ; et al.	2003-07-03
Compounds which are useful for prevention and treatment of central nervous system disorders Grant 5,616,707 - Crooks , et al. April 1, 1	1997-04-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.